When clinics prescribe the combination, AOD-9604 is typically dosed at 250 to 500 mcg daily by subcutaneous injection, sometimes given in the morning on a fasted basis based on the theory that lipolysis is more active during fasting
Its dual action on GIP and GLP-1 receptors enhances its ability to reduce blood sugar and achieve more significant weight loss compared to semaglutide
This includes investigations into its influence on insulin secretion, glucose uptake, and endothelial function
If it is, your practitioner can advise you on form and dosing
If you want to explore the broader science behind this approach, start with Why Liposomal Glutathione Is Essential for Daily Wellness
MOTS-c is a cycled protocol, not a daily-for-life peptide